These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
73 related items for PubMed ID: 3544744
1. [Prophylactic effect of etretinate on the recurrence of superficial bladder tumors--results of a randomized control study]. Yoshida O, Miyakawa M, Watanabe H, Mishina T, Okajima E, Hirao Y, Matushima M, Nihira H, Nakatsu H. Hinyokika Kiyo; 1986 Sep; 32(9):1349-58. PubMed ID: 3544744 [Abstract] [Full Text] [Related]
2. [Etretinate in the prevention of recurrences of superficial bladder tumors. Clinical trial using the double-blind method]. Charbit L, Mangin P, Rognin C, Cukier J. J Urol (Paris); 1983 Sep; 89(4):247-9. PubMed ID: 6350479 [Abstract] [Full Text] [Related]
4. [A randomized study on intravesical pirarubicin (THP) chemoprophylaxis of recurrence after transurethral resection of superficial bladder cancer]. Miki T, Nonomura N, Kojima Y, Okuyama A, Nakano E, Kiyohara H, Fujioka H, Koide T, Wakatsuki A, Kuroda H, Sugao H, Seguti T, Takeyama M, Yamaguchi S. Hinyokika Kiyo; 1997 Dec; 43(12):907-12. PubMed ID: 9488944 [Abstract] [Full Text] [Related]
10. [Prophylactic combination therapy after TUR of superficial bladder cancer]. Ao T, Uchida T, Yokoyama E, Kawakami T, Adachi K, Mashimo S, Endo T, Koshiba K. Hinyokika Kiyo; 1993 Nov; 39(11):987-91. PubMed ID: 7505523 [Abstract] [Full Text] [Related]
11. [Oral administration of 5-fluorouracil (5-FU) with intravesical chemotherapy as prophylaxis against recurrence of superficial bladder tumors]. Tanaka T, Yuasa M, Yamamoto A, Kawanishi Y, Numata A, Imagawa A. Gan No Rinsho; 1986 Sep; 32(11):1439-42. PubMed ID: 3773272 [Abstract] [Full Text] [Related]
13. The immunomodulating effect of interferon-gamma intravesical instillations in preventing bladder cancer recurrence. Giannopoulos A, Constantinides C, Fokaeas E, Stravodimos C, Giannopoulou M, Kyroudi A, Gounaris A. Clin Cancer Res; 2003 Nov 15; 9(15):5550-8. PubMed ID: 14654535 [Abstract] [Full Text] [Related]
15. Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection. Mitsumori K, Tsuchiya N, Habuchi T, Li Z, Akao T, Ohyama C, Sato K, Kato T. BJU Int; 2004 Aug 15; 94(3):317-21. PubMed ID: 15291859 [Abstract] [Full Text] [Related]
16. [An experience of OK-432 intradermal administration in superficial bladder tumors]. Tsujihashi H, Akiyama T, Kurita T, Iguchi M, Uejima S, Kataoka K, Minakata S, Kitagawa M, Sangen H. Hinyokika Kiyo; 1988 Dec 15; 34(12):2111-4. PubMed ID: 3239522 [Abstract] [Full Text] [Related]
17. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes]. Iturralde Codina A, Beyríe Tamayo W, Gozá León F, Muñoz YI. Arch Esp Urol; 2004 Dec 15; 57(6):606-18. PubMed ID: 15382436 [Abstract] [Full Text] [Related]
20. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. Divrik RT, Yildirim U, Zorlu F, Ozen H. J Urol; 2006 May 15; 175(5):1641-4. PubMed ID: 16600720 [Abstract] [Full Text] [Related] Page: [Next] [New Search]